Omalizumab – an effective and safe treatment of therapy-resistant chronic spontaneous urticaria
CsU patients showed marked improvement in symptoms and reduction of concomitant medication early after the start of omalizumab therapy. Omalizumab is an important therapeutic option in patients with severe and therapy-resistant csU.
Department of Dermatology
No abstract is available for this article.